1Dreifuss FE,Santilli N, Langer DH et al. Valproic acid hepatic fatalities:A retrospective review[J]. Neurology, 1987,37:379-85.
2Dreifuss FE, Langer DH, Moline KA et al. Valproic acid hepatic fatalities. Ⅱ. U.S. experience since 1984[J]. Neurology, 1989, 39:201-7.
3Bryant AE,Dreifuss FE. Valproic acid hepatic fatalities. Ⅲ. U.S. experience since 1986[J]. Neurology, 1996,46(2): 465-9.
4Plant N, Barber P, Horner E et al. Differential gene expression in rats following subacute exposure to the anticonvulsant sodium valproate[J]. Toxicol Appl Pharmacol, 2002,183(2):127-34.
5Graham JM, Rickwood D. Subcellular Fraction[M]. A pratical Approach. 1st ed, oxford: IRL press,1997: 112-3.
6Wan L, Richard W. Determination of free and total carnitine with a random-access chemistry analyzer[J]. Clin Chem,1998,44(4)810-6.
8Kuhara T,Inoue Y,Matsumoto M. Markedly increased omega-oxidation of valproate in fulminant hepatic failure[J]. Epilepsia,1990,31(2):214-7.
9Bicknese AR, May W, Hickey WF, Dodson WE. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity[J]. Ann Neurol, 1992,32:767-75.
10Alonso E, Girbes J, Garcia-Espana A et al. Changes in urea cycle-related metabolites in the mouse after combined administration of valproic acid and an amino acid load[J]. Arch Biochem Biophys,1989,272(2):267-73.
